Case number 2020-1164
Horizon Pharma USA, Inc. v. Dr. Reddy's Laboratories, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 8, 2020 | 28 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [699846] [MJL] [Entered: 06/08/2020 02:24 PM] (0) |
| Apr 17, 2020 | 27 | ORDER filed adding the Director of the United States Patent and Trademark Office as an intervenor.; The motion to vacate and remand [18]is granted. The Patent Trial and Appeal Board’s decision is vacated, and the case is remanded to the Board for proceedings consistent with this court’s decision in Arthrex. Each side shall bear its own costs. Service as of this date by the Clerk of Court. [687806] [NL] [Entered: 04/17/2020 11:02 AM] (0) |
| Mar 26, 2020 | 22 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 03/26/2020 by email. [681999] [20-1164] [Kakoli Caprihan] [Entered: 03/26/2020 12:53 PM] (0) |
| Mar 26, 2020 | 23 | Entry of appearance for Kakoli Caprihan as principal counsel for Intervenor - Director, U.S. Patent and Trademark Office. Service: 03/26/2020 by email. [682000] [20-1164] [Kakoli Caprihan] [Entered: 03/26/2020 12:57 PM] (0) |
| Mar 26, 2020 | 24 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor - Director, U.S. Patent and Trademark Office. Service: 03/26/2020 by email. [682007] [20-1164] [Thomas Krause] [Entered: 03/26/2020 01:06 PM] (0) |
| Mar 26, 2020 | 25 | Entry of appearance for Farheena Y. Rasheed as of counsel for Intervenor - Director, U.S. Patent and Trademark Office. Service: 03/26/2020 by email. [682013] [20-1164] [Farheena Rasheed] [Entered: 03/26/2020 01:10 PM] (0) |
| Mar 26, 2020 | 26 | RESPONSE from Intervenor - Director, U.S. Patent and Trademark Office to the motion [18] filed by Appellants Horizon Pharma USA, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company, motion [18] filed by Appellants Horizon Pharma USA, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 03/26/2020 by email. [682018] [20-1164] [Kakoli Caprihan] [Entered: 03/26/2020 01:19 PM] (0) |
| Mar 16, 2020 | 21 | REPLY of Appellants Horizon Pharma USA, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company to response [19]. Service: 03/16/2020 by email. [679260] [20-1164] [Charles Collins-Chase] [Entered: 03/16/2020 05:05 PM] (0) |
| Mar 12, 2020 | 20 | ORDER Notice of the appellants' constitutional challenge [18] is hereby certified to the Attorney General. No later than 14 days from the date of filing of this order, the Attorney General is directed to inform this court whether the United States intends to intervene in this appeal and to file any response to the motion. Service as of this date by the Clerk of Court. [678377] [LMS] [Entered: 03/12/2020 04:29 PM] (0) |
| Mar 9, 2020 | 19 | RESPONSE of Appellee Dr. Reddy's Laboratories, Inc. to the motion [18] filed by Appellants Horizon Pharma USA, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company, motion [18] filed by Appellants Horizon Pharma USA, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 03/09/2020 by email. [677393] [20-1164] [William Burgess] [Entered: 03/09/2020 10:21 PM] (0) |
| Feb 28, 2020 | 18 | MOTION of Appellants Horizon Pharma USA, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company to vacate The Board's Final Written Decision., to terminate appeal through vacate and remand this case to the Board for further proceedings. Cases to be terminated: 20-1164. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: opposed]. Service: 02/28/2020 by email. [675361] [20-1164] [Charles Collins-Chase] [Entered: 02/28/2020 08:14 PM] (54) |
| Jan 14, 2020 | 17 | Certified list received. Service: 12/30/2019 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [662939] [TAM] [Entered: 01/14/2020 02:32 PM] (49) |
| Dec 3, 2019 | 12 | Entry of appearance for Michael Hawes as principal counsel for Appellant Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 12/03/2019 by email. [653777] [20-1164] [Michael Hawes] [Entered: 12/03/2019 04:28 PM] (2) |
| Dec 3, 2019 | 13 | Docketing Statement for the Appellant Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 12/03/2019 by email. [653779] [20-1164] [Michael Hawes] [Entered: 12/03/2019 04:30 PM] (3) |
| Dec 3, 2019 | 14 | Certificate of Interest for Appellant Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 12/03/2019 by email. [653783] [20-1164] [Michael Hawes] [Entered: 12/03/2019 04:31 PM] (3) |
| Dec 3, 2019 | 15 | Entry of appearance for Stephen M. Hash as of counsel for Appellant Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 12/03/2019 by email. [653788] [20-1164] [Stephen Hash] [Entered: 12/03/2019 04:39 PM] (2) |
| Dec 3, 2019 | 16 | Entry of appearance for Jeff Gritton as of counsel for Appellant Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Service: 12/03/2019 by email. [653789] [20-1164] [Jeffrey Gritton] [Entered: 12/03/2019 04:41 PM] (2) |
| Dec 2, 2019 | 7 | Entry of appearance for Charles T. Collins-Chase as of counsel for Appellant Horizon Pharma USA, Inc.. Service: 12/02/2019 by email. [653373] [20-1164] [Charles Collins-Chase] [Entered: 12/02/2019 08:25 PM] (1) |
| Dec 2, 2019 | 8 | Entry of appearance for James B. Monroe as principal counsel for Appellant Horizon Pharma USA, Inc.. Service: 12/02/2019 by email. [653374] [20-1164] [Charles Collins-Chase] [Entered: 12/02/2019 08:28 PM] (1) |
| Dec 2, 2019 | 9 | Entry of appearance for C. Collette Corser as of counsel for Appellant Horizon Pharma USA, Inc.. Service: 12/02/2019 by email. [653375] [20-1164] [Charles Collins-Chase] [Entered: 12/02/2019 08:30 PM] (1) |
| Dec 2, 2019 | 10 | Certificate of Interest for Appellant Horizon Pharma USA, Inc.. Service: 12/02/2019 by email. [653377] [20-1164] [Charles Collins-Chase] [Entered: 12/02/2019 08:35 PM] (2) |
| Dec 2, 2019 | 11 | Docketing Statement for the Appellant Horizon Pharma USA, Inc.. Service: 12/02/2019 by email. [653378] [20-1164] [Charles Collins-Chase] [Entered: 12/02/2019 08:37 PM] (3) |
| Nov 27, 2019 | 2 | Entry of appearance for John C. O'Quinn as principal counsel for Appellee Dr. Reddy's Laboratories, Inc.. Service: 11/27/2019 by email. [652853] [20-1164] [William Burgess] [Entered: 11/27/2019 01:36 PM] (2) |
| Nov 27, 2019 | 3 | Entry of appearance for Alan H. Pollack as of counsel for Appellee Dr. Reddy's Laboratories, Inc.. Service: 11/27/2019 by email. [652855] [20-1164] [William Burgess] [Entered: 11/27/2019 01:37 PM] (2) |
| Nov 27, 2019 | 4 | Entry of appearance for William H. Burgess as of counsel for Appellee Dr. Reddy's Laboratories, Inc.. Service: 11/27/2019 by email. [652859] [20-1164] [William Burgess] [Entered: 11/27/2019 01:38 PM] (2) |
| Nov 27, 2019 | 5 | Certificate of Interest for Appellee Dr. Reddy's Laboratories, Inc.. Service: 11/27/2019 by email. [652860] [20-1164] [William Burgess] [Entered: 11/27/2019 01:40 PM] (3) |
| Nov 27, 2019 | 6 | Docketing Statement for the Appellee Dr. Reddy's Laboratories, Inc.. Service: 11/27/2019 by email. [652864] [20-1164] [William Burgess] [Entered: 11/27/2019 01:42 PM] (3) |
| Nov 18, 2019 | 1 | Appeal docketed. Received: 11/08/2019. [650161] Entry of Appearance due 12/02/2019. Certificate of Interest is due on 12/02/2019. Docketing Statement due 12/02/2019. Certified List due on 12/30/2019. [TAM] [Entered: 11/18/2019 02:04 PM] (50) |
